Skip to Main Content

Author Details

Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
2000
221
35
PMIDPaper TitleJournal TitlePublished Year
37118959Nomogram Using Prostate Health Index for Predicting Prostate Cancer in the Gray Zone: Prospective, Multicenter Study.World J Mens Health2024
36254631Repression of SLC22A3 by the AR-V7/YAP1/TAZ axis in enzalutamide-resistant castration-resistant prostate cancer.FEBS J2023
37745907Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer.Prostate Int2023
37509551Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer.Biomedicines2023
37409092Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy.Prostate Int2023
37376735Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study.J Yeungnam Med Sci2023
36835404Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.Int J Mol Sci2023
36929129New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles' operation.Insights Imaging2023
36167777Chromosomal Instability in Cell-free DNA as a Prognostic Biomarker of Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy.Eur Urol Focus2023
35141158TRUS-Guided Target Biopsy for a PI-RADS 3-5 Index Lesion to Reduce Gleason Score Underestimation: A Propensity Score Matching Analysis.Front Oncol2022
35510096Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1-2 on multiparametric magnetic resonance imaging.Prostate Int2022
35675311Correction: Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value.PLoS One2022
35574412A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.Front Oncol2022
35626196Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer.Diagnostics (Basel)2022
35626101Robotic Radical Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma: A Trend Analysis of Utilization and a Comparative Study.Cancers (Basel)2022
35625960Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma.Cancers (Basel)2022
36291981A Comparison of Functional and Oncologic Outcomes between Partial Nephrectomy and Radiofrequency Ablation in Patients with Chronic Kidney Disease after Propensity Score Matching.Diagnostics (Basel)2022
36077710Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions.Cancers (Basel)2022
33857365Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma.Cancer Res Treat2022
33421984Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.Cancer Res Treat2021
33692449Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma.Sci Rep2021
33837237Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma.Sci Rep2021
33660451Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance.Investig Clin Urol2021
33916347Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities.Biology (Basel)2021
34944964Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer.Cancers (Basel)2021
34753938Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels.Sci Rep2021
34692504Conditional Intravesical Recurrence-Free Survival Rate After Radical Nephroureterectomy With Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.Front Oncol2021
34839812A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer.BMC Cancer2021
34768437Preoperative versus Postoperative Compensation of the Contralateral Normal Kidney in Patients Treated with Radical Nephrectomy for Renal Cell Carcinoma.J Clin Med2021
34768322The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy.J Clin Med2021
33939714Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value.PLoS One2021
34262353Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?Cancer Manag Res2021
34235097Comparison of Risk Factors for the Development of Proteinuria After Radical Nephrectomy for Renal Cell Carcinoma.Res Rep Urol2021
31621405Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors.J Endourol2020
33193883Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis.J Cancer2020
33135403Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5-10 ng/mL.Investig Clin Urol2020
33107227Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL).J Korean Med Sci2020
33102394Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients.Prostate Int2020
32738549Relationship between robotic-assisted radical prostatectomy and retropubic radical prostatectomy in the learning curve of a single surgeon as a novice in radical prostatectomy: A retrospective cohort study.Int J Surg2020
32985144Docetaxel rechallenge in metastatic castration-resistant prostate cancer: A retrospective, single-center study.Investig Clin Urol2020
32724485Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment.Dis Markers2020
32252440Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study.Cancers (Basel)2020
30636627Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy.Diagn Pathol2019
31702677Stratification based on adverse laboratory/pathological features for predicting overall survival in patients undergoing radical prostatectomy: A K-CaP registry-based analysis.Medicine (Baltimore)2019
31839824Role of Adjuvant Chemotherapy in Advanced Stage Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy: Competing Risk Analysis after Propensity Score-Matching.J Cancer2019
31692988The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy.Investig Clin Urol2019
31473122Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors.Clin Genitourin Cancer2019
31269509Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.Urol Int2019
31213917Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion.Cancer Manag Res2019
31294131Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing.Investig Clin Urol2019
  • 1 - 50 of 221

Recommended Authors

Giovanni Motterle
Mayo Clinic
Career Start Year 2017
Number of shared co-authors 0
Jamil S Syed
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Yue Yang
Institute of Cancer Prevention and Treatment, Harbin Medical University
Career Start Year 2015
Number of shared co-authors 0
Francesco Pellegrino
Urological Research Institute, IRCCS San Raffaele Hospital
Career Start Year 2012
Number of shared co-authors 0
Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year 2012
Number of shared co-authors 0
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 0
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 0
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 0
Aydin Pooli
David Geffen School of Medicine, University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 0
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 0
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 1
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 0
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Career Start Year 2002
Number of shared co-authors 1
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 0
Karim Chamie
David Geffen School of Medicine at university of california los angeles
Career Start Year 2001
Number of shared co-authors 0
Robert Jeffrey Karnes
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 0
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 1
Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 0
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 0
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 0
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 1
Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year 1993
Number of shared co-authors 0
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 1
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 0
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 1
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 0
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 1

Collaborators

Seong Il Seo
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 162
Byong Chang Jeong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 149
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 18
Byung Ha Chung
Yonsei University College of Medicine and Gangnam Severance Hospital
Co-authored papers 15
Ji Youl Lee
Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Co-authored papers 14
Seok-Soo Byun
Seoul National University Bundang Hospital
Co-authored papers 12
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Co-authored papers 12
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Co-authored papers 9
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 7
Chang Wook Jeong
Seoul National University Hospital, Seoul National University College of Medicine
Co-authored papers 7
In Young Choi
The Catholic University of Korea College of Medicine
Co-authored papers 7
Seok Soo Byun
Seoul National University Bundang Hospital
Co-authored papers 6
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 5
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 4
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 3
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 2
Joon Oh Park
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Co-authored papers 2
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers 2
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 1
Tomasz M Beer
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Kyung Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Young Mog Shim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Yong-Jun Kwon
Luxembourg Institute of Health
Co-authored papers 1
Yejin Kim
University of Texas Health Science Center at Houston
Co-authored papers 1
Eun Young Kim
College of Korean Medicine, Kyung Hee University
Co-authored papers 1
Hee Jin Cho
Touro College of Osteopathic Medicine
Co-authored papers 1
Hwanjo Yu
Pohang University of Science and Technology
Co-authored papers 1
Kyoung-Mee Kim
Seoul National University College of Medicine
Co-authored papers 1
Release 1.2